{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:04:01Z","timestamp":1763366641827},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1067\/mob.2000.108884","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:17:12Z","timestamp":1027570632000},"page":"1114-1118","source":"Crossref","is-referenced-by-count":12,"title":["Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies"],"prefix":"10.1067","volume":"183","author":[{"given":"Ray O.","family":"Bahado-Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utku","family":"Oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohreh","family":"Shahabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice J.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Baumgarten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence A.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mob.2000.108884_bib1","first-page":"28","article-title":"Royalty fees may put hCG test out of business","volume":"32","author":"Zoler","year":"1997","journal-title":"Ob Gyn News"},{"key":"10.1067\/mob.2000.108884_bib2","first-page":"31","article-title":"Risk estimation in Down\u2019s syndrome screening policy and practice","author":"Cuckle","year":"1990"},{"key":"10.1067\/mob.2000.108884_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJM199404213301603","article-title":"Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening","volume":"330","author":"Haddow","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1067\/mob.2000.108884_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJM199107043250102","article-title":"Second trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death","volume":"325","author":"Waller","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mob.2000.108884_bib5","first-page":"83","article-title":"The association between unexplained second trimester serum hCG elevation and pregnancy complications","volume":"80","author":"Gonen","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1067\/mob.2000.108884_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/(SICI)1097-0223(199904)19:4<351::AID-PD546>3.0.CO;2-X","article-title":"Urinary screening tests for fetal Down syndrome. II. Hyperglycosylated hCG","volume":"19","author":"Cole","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1067\/mob.2000.108884_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/sim.4780110211","article-title":"Model based screening for risk with application to Down\u2019s syndrome","volume":"11","author":"Royston","year":"1992","journal-title":"Stat Med"},{"key":"10.1067\/mob.2000.108884_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00365519509088450","article-title":"Software for illustrative presentation of basic clinical characteristics of laboratory tests. Graph ROC for Windows","volume":"55","author":"Kairisto","year":"1995","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1067\/mob.2000.108884_bib9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00006250-200006000-00020","article-title":"Urine hyperglycosylated hCG plus ultrasound biometry for mid-trimester Down syndrome detection in a high risk population","volume":"95","author":"Bahado-Singh","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1067\/mob.2000.108884_bib10","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/clinchem\/45.12.2109","article-title":"Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening","volume":"45","author":"Cole","year":"1999","journal-title":"Clin Chem"},{"key":"10.1067\/mob.2000.108884_bib11","series-title":"Maternal serum screening","author":"American College of Obstetricians and Gynecologists","year":"1996"},{"key":"10.1067\/mob.2000.108884_bib12","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0002-9378(98)70036-5","article-title":"New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age","volume":"179","author":"Bahado-Singh","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2000.108884_bib13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0002-9378(95)91372-6","article-title":"Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women \u226535 years old","volume":"173","author":"Wenstrom","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2000.108884_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00006254-199806000-00022","article-title":"Triple-marker test as screening for Down syndrome: a meta-analysis","volume":"53","author":"Conde-Agudelo","year":"1998","journal-title":"Obstet Gynecol Surv"},{"key":"10.1067\/mob.2000.108884_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1177\/000456329803500608","article-title":"Dissociation of hCG into its free subunits is dependent on naturally occurring molecular structural variations","volume":"35","author":"Butler","year":"1998","journal-title":"Ann Clin Biochem"},{"key":"10.1067\/mob.2000.108884_bib16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0002-9378(99)70327-3","article-title":"Elevated maternal urine level of \u03b2-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of Down syndrome","volume":"181","author":"Bahado-Singh","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2000.108884_bib17","first-page":"141","article-title":"Is the measurement of unconjugated oestriol of value in screening for Down\u2019s syndrome?","author":"Spencer","year":"1990"},{"key":"10.1067\/mob.2000.108884_NEWBIB1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pd.1970121005","article-title":"Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down\u2019s syndrome","volume":"12","author":"Van Lith","year":"1992","journal-title":"Prenat Diagn"},{"key":"10.1067\/mob.2000.108884_bib19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0002-9378(99)70320-0","article-title":"Prospective evaluation of free \u03b2-subunit of human chorionic gonadotropin and dimeric inhibin-A for aneuploidy detection","volume":"181","author":"Wenstrom","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2000.108884_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/pd.1970150416","article-title":"Maternal serum dimeric inhibin\u2013A in second trimester Down\u2019s syndrome pregnancies","volume":"15","author":"Cuckle","year":"1995","journal-title":"Prenat Diagn"},{"key":"10.1067\/mob.2000.108884_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2265.1996.544368.x","article-title":"Second trimester screening for Down\u2019s syndrome using maternal serum dimeric inhibin\u2013A","volume":"44","author":"Wallace","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1067\/mob.2000.108884_bib22","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1101::AID-PD5>3.0.CO;2-7","article-title":"Second-trimester dimeric inhibin\u2013A in Down\u2019s syndrome screening","volume":"16","author":"Spencer","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1067\/mob.2000.108884_bib23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1095::AID-PD997>3.0.CO;2-9","article-title":"Combining inhibin\u2013A with existing second-trimester markers in maternal serum screening for Down\u2019s syndrome","volume":"16","author":"Cuckle","year":"1996","journal-title":"Prenat Diagn"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293780024369X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293780024369X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:45:49Z","timestamp":1620002749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293780024369X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["S000293780024369X"],"URL":"https:\/\/doi.org\/10.1067\/mob.2000.108884","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}